Bay Street News, February 14th, 2024

Company announces preliminary fourth-quarter 2023 revenue record in excess of $42 million, as well as a record-breaking full-year 2023 revenue […]

Fourth quarter revenues of $56.6 million, in line with previous guidance Fourth quarter GAAP net loss of $22.9 million; non-GAAP […]

Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase […]

SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments […]

CAMBRIDGE, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on […]

Fourth quarter net income increased by 4% year-over-year despite consolidated revenue declining by 2% Fourth quarter Agriculture segment adjusted EBIT […]

SMB Solutions Equipped With Countermeasures Against Business Email Compromise Cyberattacks – Average Revenue Per User to Increase 40% NEW YORK, […]

With the Response Rate increasing to 23%, MDNA11 continues to show compelling single-agent activity in the ABILITY-1 study amongst high-dose […]

MONTREAL, Feb. 14, 2024 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to give an overview of […]

NORCROSS, Ga., Feb. 14, 2024 (GLOBE NEWSWIRE) — CoreCard Corporation (NYSE: CCRD) (“CoreCard” or “the Company”), the leading provider of […]